Shukra Pharma shareholders approve name change to Shukra Medtech
Shukra Pharmaceuticals Ltd. announced the voting results of its postal ballot conducted via remote e-voting from August 28 to September 26, 2026. Shareholders approved two key resolutions. The first resolution, concerning an amendment in the Object Clause of the Memorandum of Association, passed with an overwhelming 99.97% of votes in favour. The second resolution, to change the company's name from "Shukra Pharmaceuticals Limited" to "Shukra Medtech Limited" and amend the Memorandum and Articles of Association, also received strong approval with 99.93% of votes in favour. Both resolutions are deemed passed as of September 26, 2026, enabling the company to proceed with these significant corporate actions.
Key Highlights
- Shareholders approved two resolutions via postal ballot.
- MoA Object Clause amendment passed with 99.97% votes in favour.
- Name change to "Shukra Medtech Limited" passed with 99.93% votes.
- Voting was conducted remotely from August 28 to September 26, 2026.
- Both resolutions are now deemed passed by shareholder approval.
Price Impact
More from SHUKRAPHAR